Eprobemide

Eprobemide
Clinical data
Other names	Befol
Identifiers
	IUPAC name 4-Chloro-N-[3-(4-morpholinyl)propyl]benzamide;
CAS Number	87940-60-1;
PubChem CID	65659;
ChemSpider	59094;
CompTox Dashboard (EPA)	DTXSID3046409 ;
Chemical and physical data
Formula	C14H19ClN2O2
Molar mass	282.77 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl;
	InChI InChI=1S/C14H19ClN2O2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5H,1,6-11H2,(H,16,18); Key:YYFGRAGNYHYWEZ-UHFFFAOYSA-N;

Eprobemide (INN) is a pharmaceutical drug used as an antidepressant.^[1] It is a reverse inhibitor of monoaminoxidase^[2] that exhibits selective action on serotonin deamination.^[3]

References

^ C.R. Ganellin, David J. Triggle (1996). Dictionary of Pharmacological Agents. Vol. 3. p. 811. ISBN 978-0412466304.
^ Gol'Dina, OA; Moskvitina, TA; Gankina, EM; Kirkel', AZ; Kamyshanskaia, NS; Lopatina, KI; Sokolova, TV; Zagorevskiĭ, VA; Val'Dman, AV; Gorkin, VZ (1991). "The action of befol and its derivatives on monoamine oxidase of different origins". Biulleten' eksperimental'noi biologii i meditsiny. 111 (3): 279–80. PMID 2054504.
^ Eprobemide, ChemIDplus

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[1] C.R. Ganellin, David J. Triggle (1996). Dictionary of Pharmacological Agents. Vol. 3. p. 811. ISBN 978-0412466304.

[2] Gol'Dina, OA; Moskvitina, TA; Gankina, EM; Kirkel', AZ; Kamyshanskaia, NS; Lopatina, KI; Sokolova, TV; Zagorevskiĭ, VA; Val'Dman, AV; Gorkin, VZ (1991). "The action of befol and its derivatives on monoamine oxidase of different origins". Biulleten' eksperimental'noi biologii i meditsiny. 111 (3): 279–80. PMID 2054504.

[3] Eprobemide, ChemIDplus

[1]

[2]

[3]